424 publications from this institution
The frequencies of monocycles and of primary rings in 1:1 - and 1:2-fused polycycles have been analysed by means of a simple and rapid computer procedure. The analysis deals with the great majority of ring systems in a sample of the Chemical Abstracts Registry System. The data are presented in terms of ring sizes and composition. In each case, the preponderance of six-membered carbocyclic rings is evident.
In an effort to provide insight into the role of mutation in the maintenance of genetic variance for life-history traits, we accumulated spontaneous mutations in 10 sets of clonal replicates of Daphnia pulex for approximately 30 generations and compared the variance generated by mutation with the standing level of variation in the wild population. Mutations for quantitative traits appear to arise at a fairly high rate in this species, on the order of at least 0.6 per character per generation, but have relatively small heterozygous effects, changing the phenotype by less than 2.5% of the mean. The mean persistence time of a new mutation affecting life-history/body-size traits is approximately 40 generations in the natural population, which requires an average selection coefficient against new mutations of approximately 3% in the heterozygous state. These data are consistent with the idea that the vast majority of standing genetic variance for life-history characters may be largely a consequence of the recurrent introduction of transient cohorts of mutations that are at least conditionally deleterious and raise issues about the meaning of conventional measures of standing levels of variation for fitness-related traits.
<h3>Background</h3> Chimeric Antigen Receptor (CAR) T cell therapy is a new type of "living drug" that has proven to be a powerful immunotherapy for hematologic malignancies. To date, there are six CAR-T products approved by FDA, four CD19 targeted CAR-T cells, and two targeting B-cell maturation antigen (BCMA).<sup>1-8</sup> However, this success has not yet been transferred to solid tumors. A major hurdle is the on-target off-tumor toxicities due to the shared expression of target antigen on healthy tissues. <h3>Methods</h3> Here, we assessed the <i>in vitro</i> cytotoxicity of carbonic anhydrase IX (CAIX) targeted CAR-T cells generated from a series of single chain fragment variables (scFvs) that have various affinities against CAIX. In addition, we studied the avidity of CAR-T cells using a cell avidity analyzer. We established a tetracycline (Tet)-On inducible CAIX expressing system that provides different CAIX levels on the cell surface covering the range from the density on CAIX-high skrc-59 cells to the one on CAIX-low MMNK-1 cholangiocytes. To assess the therapeutic effect of CAR-T on patient samples, we generated patient derived organotypic spheroids (PDOTS) <i>ex vivo</i> cultures and tested CAR-T cell migration and cytokine release using these miniature tumors. <h3>Results</h3> We identified a low affinity, high avidity anti-CAIX CAR G9, which only kills CAIX high tumor cells but not CAIX-low normal tissues <i>in vitro</i>. G9 demonstrates a CAIX density dependent response on Tet-On inducible CAIX expressing cell lines. G9 CAR has a wider therapeutic window compared to G250 that caused serious adverse events in the first anti-CAIX CAR-T clinal trial.<sup>9-11</sup> G9 exhibits superior efficacy <i>ex vivo</i> on ccRCC PDOTS 3D cultures which recapitulates ccRCC patient tumor microenvironment (TME), as well as mitigating toxicity on cholangiectasis spheroids. <h3>Conclusions</h3> In summary, affinity fine-tuned CAR-T cell therapy holds the promise to achieve cures of ccRCC by killing ccRCC tumor cells and mitigating on-target off-tumor toxicity on normal tissues. <h3>References</h3> Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H. <i>et al</i>. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. <i>N Engl J Med</i>. 2018; Feb 1; <b>378</b>: 439-448, doi:10.1056/NEJMoa1709866. Schuster, S. J., Bishop, M. R., Tam, C. S., Waller, E. K., Borchmann, P., McGuirk, J. P. <i>et al</i>. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.<i>N Engl J Med</i>. 2019; Jan 3; <b>380</b>: 45-56, doi:10.1056/NEJMoa1804980 Wang, M., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T. <i>et al</i>. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.<i>N Engl J Med</i>. 2020; Apr 2; <b>382</b>: 1331-1342, doi:10.1056/NEJMoa1914347. Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J. <i>et al</i>. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. <i>Lancet</i>. 2020; Sep 19; <b>396</b>: 839-852, doi:10.1016/s0140-6736(20)31366-0 Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A. <i>et al</i>. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.<i>N Engl J Med</i>. 2017; Dec 28; <b>377</b>: 2531-2544, doi:10.1056/NEJMoa1707447. Locke, F. L., Ghobadi, A., Jacobson, C. A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O. <i>et al</i>. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.<i>Lancet Oncol</i>. 2019; Jan; <b>20</b>: 31-42, doi:10.1016/s1470-2045(18)30864-7. FDA.FDA Approves First Cell-Based Gene Therapy for Adult Patients With Multiple Myeloma. 2021; Mar 27. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-cell-based-gene-therapy-adult-patients-multiple-myeloma.: Berdeja, J. G., Madduri, D., Usmani, S. Z., Jakubowiak, A., Agha, M., Cohen, A. D. <i>et al</i>. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.<i>Lancet</i>. 2021; Jul 24; <b>398</b>: 314-324, doi:10.1016/s0140-6736(21)00933-8 Lamers, C. H., Klaver, Y., Gratama, J. W., Sleijfer, S. & Debets, R. Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview. <i>Biochem Soc Trans</i>. 2016; Jun 15; <b>44</b>: 951-959, doi:10.1042/bst20160037 Lamers, C. H., Sleijfer, S., Vulto, A. G., Kruit, W. H., Kliffen, M., Debets, R. <i>et al</i>. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.<i>J Clin Oncol</i>. 2006; May 1; <b>24</b>: e20-22, doi:10.1200/jco.2006.05.9964 Lamers, C. H., Willemsen, R., van Elzakker, P., van Steenbergen-Langeveld, S., Broertjes, M., Oosterwijk-Wakka, J. <i>et al</i>. Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells.<i>Blood</i>. 2011; Jan 6; <b>117</b>: 72-82, doi:10.1182/blood-2010-07-294520 <h3>Ethics Approval</h3> The study obtained DFCI Office for Human Research Studies (OHRS) approval (IRB protocol #19-194).
In a 2018 paper and a subsequent article published in 2023, researchers reported that mitochondria maintain temperatures 10-15 degrees higher than the surrounding cytoplasm - a finding that deviates by 5 to 6 orders of magnitude from theoretical predictions based on Fourier s law of heat conduction. In 2022, we proposed a solution to this apparent paradox. In the present perspective, we build upon that framework and introduce new ideas to further unravel how a biological membrane - whether of an organelle or a whole cell - can become significantly warmer than its environment. We propose that proteins embedded in the inner mitochondrial membrane (IMM) can be modeled as ratchet engines, introducing a novel, previously overlooked mode of heat transfer. This mechanism, coupled with localized heat release during the cyclical dehydration-translocation-hydration of ions through membrane proteins, may generate transient but substantial temperature spikes. In the case of protons, the cycle additionally includes deprotonation before translocation and protonation after. The cumulative effect of these microscopic events across the three-dimensional surface of the IMM can account for the elevated temperatures detected by molecular probes. We also offer a hypothesis based on quantum chemical calculations on how such probes might detect these fleeting thermal signatures.
When a favorable allele increases in frequency, it alters the coalescent structure (the pattern of times back to a common ancestor) at linked sites relative to that under drift. This creates patterns of sequence polymorphism than can be used to potentially detect ongoing, or very recent, selection. This idea of a neutral allele hitchhiking up to high frequency when coupled to a favorable allele is the notion of a selective sweep, and this chapter reviews the considerable body of associated population-genetics theory on sweeps. Different types of sweeps leave different signatures, resulting in the very diverse collection of tests of selection discussed in Chapter 9. Either a history of recurrent sweeps, or of background selection, results in linked genomic regions of reduced effective population size. This implies that more mutations in sich regions are efficiently neutral, which can result in increased substitution rates and lower codon bias. Finally, the chapter examines the theory for when response is expected to start from existing variation, as opposed to waiting for the appearance of new mutations.
Abstract Applications of quantitative genetics and conservation genetics often require measures of pairwise relationships between individuals, which, in the absence of known pedigree structure, can be estimated only by use of molecular markers. Here we introduce methods for the joint estimation of the two-gene and four-gene coefficients of relationship from data on codominant molecular markers in randomly mating populations. In a comparison with other published estimators of pairwise relatedness, we find these new “regression” estimators to be computationally simpler and to yield similar or lower sampling variances, particularly when many loci are used or when loci are hypervariable. Two examples are given in which the new estimators are applied to natural populations, one that reveals isolation-by-distance in an annual plant and the other that suggests a genetic basis for a coat color polymorphism in bears.